Thomas Sené
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
Papers in
-
- Ocular Diseases and Behçet’s Syndrome 7
-
- Vasculitis and related conditions 15
- Co-authors
- Augustin Lecler (13 shared papers)Catherine Vignal (10 shared papers)Jean-Marc Ziza (9 shared papers)Olivier Lidove (10 shared papers)Gaëlle Clavel (9 shared papers)Julien Savatovsky (6 shared papers)Hervé Picard (3 shared papers)Kévin Zuber (4 shared papers)
- Journals
- Medicine (4 papers)Lara D. Veeken (4 papers)European Radiology (3 papers)Ocular Immunology and Inflammation (3 papers)RMD Open (2 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Thomas Sené
55 papers receiving 1.3k citations
Thomas Sené's Hit Papers
Peers
Comparison fields: 5 of 77
- Applied Microbiology and Biotechnology 33
- Rheumatology 233
- Hematology 163
- Ophthalmology 123
- Nephrology 94
Countries citing papers authored by Thomas Sené
This map shows the geographic impact of Thomas Sené's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Sené with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Sené more than expected).
Fields of papers citing papers by Thomas Sené
This network shows the impact of papers produced by Thomas Sené. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Sené. The network helps show where Thomas Sené may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Sené, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study Hit paper breakdown → | 2021 | 209 |
| 2 | 2015 | 121 | |
| 3 | 2017 | 117 | |
| 4 | 2021 | 109 | |
| 5 | 2017 | 105 | |
| 6 | 2021 | 57 | |
| 7 | 2017 | 49 | |
| 8 | 2019 | 39 | |
| 9 | 2021 | 35 | |
| 10 | 2016 | 27 | |
| 11 | 2016 | 22 | |
| 12 | 2024 | 22 | |
| 13 | 2016 | 20 | |
| 14 | 2015 | 19 | |
| 15 | 2021 | 19 | |
| 16 | 2022 | 19 | |
| 17 | 2018 | 18 | |
| 18 | 2020 | 17 | |
| 19 | 2021 | 17 | |
| 20 | 2021 | 17 |
About Thomas Sené
Thomas Sené is a scholar working on Ophthalmology, Pulmonary and Respiratory Medicine, Rheumatology, Physiology and Neurology, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include Vasculitis and related conditions (15 papers), Ocular Diseases and Behçet’s Syndrome (7 papers), Lysosomal Storage Disorders Research (5 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), COVID-19 Clinical Research Studies (2 papers), Otitis Media and Relapsing Polychondritis (2 papers) and Cerebral Venous Sinus Thrombosis (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (33 citations), Rheumatology (233 citations), Hematology (163 citations), Ophthalmology (123 citations) and Nephrology (94 citations). Thomas Sené has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Augustin Lecler, Catherine Vignal, Jean-Marc Ziza, Olivier Lidove, Gaëlle Clavel, Julien Savatovsky, Hervé Picard, Kévin Zuber, Frédérique Charbonneau and Valérie Zeller. Their work appears in journals such as Medicine, Lara D. Veeken, European Radiology, Ocular Immunology and Inflammation and RMD Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.